Christopher Cooper
Co-Chief Executive Officer at Shuttle Pharmaceuticals.
Earliest Form D on file: May 2026
Filed May 15, 2026
Shuttle Pharmaceuticals
Radiation-sensitizing drug for glioblastoma
Biotech, Gaithersburg MD
Signed as Co-Chief Executive Officer
Network
At Shuttle Pharmaceuticals
5 peopleDirector
Director
Director
Executive Officer
Executive Officer